This easy-to-follow reference chart shows those medications that have been approved by the FDA and are available for the long-term treatment of relapsing forms of MS. This chart does not address the issues of efficacy, safety, and risk.
All of these disease-modifying therapies (DMTs) for MS have different benefits and risks. The effectiveness and side effects of each medication may vary from one person to another. Additionally, individuals who do not respond well to one DMT may benefit by switching to a different treatment.
Individuals need to consult with their healthcare team to determine which treatment might be the best option for them. For additional information on the specific treatments, administration, and side effects, please refer to Appendix #2.
As a reminder, the 13 disease-modifying therapies (DMTs) for MS shown in this chart are limited to those approved by the FDA as of the printing of this booklet. At any time, more long-term treatments may become available as new medications complete the clinical-trial process and are submitted to the FDA for approval. To learn more about these approved treatments as well as new medications as they become approved, please visit MSAA’s website at mymsaa.org and select “Treatments” under “MS Information.” The image above is a screenshot from MSAA’s website, showing the treatments landing page.